FDA Approved: OTULFI — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved OTULFI (ustekinumab-aauz) from Fresenius Kabi USA, LLC, as an original application. OTULFI is a monoclonal antibody targeting IL-12 and IL-23 and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• OTULFI (USTEKINUMAB-AAUZ)

Snippet

ORIG AP for OTULFI (USTEKINUMAB-AAUZ)